Autocrine IL6 and ERβ may represent a positive feedback loop, and synergistic inhibition of ERβ and IL6 may serve as a potential target for prognostic assessment and therapeutic intervention in lung cancer. This evidence concerns the gene ESR2 and lung carcinoma.